Navigation Links
1st SynCardia Total Artificial Heart Implant Performed in New England
Date:7/11/2012

TUCSON, Ariz., July 11, 2012 /PRNewswire/-- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.

(Photo:  http://photos.prnewswire.com/prnh/20120711/LA38332)

"If I didn't have this device, I probably would have ended up dying," said patient Jim Carelli, Jr. "It's not a difficult choice when you want to live - and I wanted to live."

Mr. Carelli, 66, is a former high school science teacher and track coach who taught for 32 years before retiring in 2004. He was an avid runner and golfer until three years ago, when he experienced an irregular heartbeat. In 2010, he was diagnosed with late-stage cardiac amyloidosis, a disorder that causes protein in the blood to build up in the heart muscle. Over time, the protein causes the heart muscle to thicken and weaken until eventually the heart begins to fail.

By February 2012, he was in need of a heart transplant to survive, but no matching donor heart was available. To save his life, on Feb. 17, doctors at Brigham and Women's performed the region's first implant of the Total Artificial Heart to bridge him to a heart transplant.

"This was the power of teamwork and the strength and courage of an individual," said Dr. Michael Givertz, medical director of the Heart Transplant and Mechanical Circulatory Support Program. "He's a courageous, resilient man with an amazing joy for life."

At a press conference at Brigham and Women's Hospital, Mr. Carelli's surgeon, Dr. Gregory Couper, said he had "never seen a heart this thick," when describing his patient's pre-surgery condition. "This procedure is life-saving and life-restoring for these patients," he added.

Prior to receiving the SynCardia Total Artificial Heart, Mr. Carelli's heart problems caused fluid to build up in his body, which created kidney problems and swelling of his legs that made it hard to walk. He is currently undergoing dialysis and has been listed for a combined heart and kidney transplant. Except for his pre-existing kidney issues, doctors said his recovery so far has been "complication free."

"You've got to have faith," said Mr. Carelli. "This is a big leap of faith. They remove your heart, and there is no turning back. Once it's gone, they're not going to give it back to you."

Today, Mr. Carelli says he feels so good that if he wasn't tethered to the hospital driver that powers his Total Artificial Heart, he'd be out running. He's currently walking 1.5 miles at a time on the treadmill.

"I'm glad people will realize that if you have a serious heart problem, you now have an alternative with this device," said Mr. Carelli. "It might take months to get a donor, but at least you'll get through it. This procedure provides great hope, which matters because sometimes people have no hope at all."

During the 10-year pivotal clinical study that resulted in FDA approval, the SynCardia Total Artificial Heart achieved the highest bridge to transplant rate, 79%, of any approved mechanical circulatory support device in the world (NEJM 2004; 351:859-67).

View news coverage of Brigham and Women's 1st implant
Watch video of Mr. Carelli telling his story
Read Mr. Carelli's story on Brigham and Women's Health Blog
Like SynCardia on Facebook
Follow SynCardia on Twitter - @SynCardia
Connect with SynCardia on LinkedIn

About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart… read more


'/>"/>
SOURCE SynCardia Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
2. SynCardia Posts Record Revenue and Profit in Q1 2012
3. Total Therapeutic Management, Inc. invites directors of quality improvement to learn secrets of provider engagement strategies
4. MDHI in Agreement with Debt Holders - Portion of Convertible Debt and Additional 14M Warrants Cancelled -- Total of 101M Warrants Cancelled this Year
5. Retired Pro Hockey Player 1st to Receive Total Artificial Heart in Upstate New York
6. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Arbor Pharmaceuticals partners with the Association of Black Cardiologists to further the campaign of "Saving Hearts of a Diverse America"
9. HeartWare Names Peter F. McAree Chief Financial Officer
10. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
11. Clinical Trial First to Test Heart Drug Regimen for Duchenne Muscular Dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):